Reliability and validity of the Turkish version of Post-COVID-19 Functional Status Scale

Çalık-Kütükçü, Ebru; Çakmak, Aslıhan; KINACI, Esra; Uyaroğlu, Oğuz Abdullah; Vardar-Yağlı, Naciye; Güven, Gülay Sain; Sağlam, Melda; Özışık, Lale; Başaran, Nursel Çalık; İnce, Deni̇z İnal

doi:10.3906/sag-2105-125

Cited by 20 publications

(23 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These findings further support the previous hypothesis that the CSI captures a broad spectrum of symptomatology and not only evaluates central nervous system processing in response to nociception. The currently obtained values on the LCADL (median 22/75, Q1–Q3: 17.25–27.50) for dyspnea-related limitation in activities of daily living are in line with the mean value of 17 (SD: 5.7) that was revealed in a population of post-COVID-19 patients in Turkey [ 53 ]. Despite the fact that most patients in this study were female (71.4%), females had more dyspnea-related limitations in activities of daily living and more central-sensitization-associated symptoms compared to males.…”

Section: Discussionsupporting

confidence: 80%

Association between Experimental Pain Measurements and the Central Sensitization Inventory in Patients at Least 3 Months after COVID-19 Infection: A Cross-Sectional Pilot Study

Goudman

Smedt

Roggeman

et al. 2023

JCM

View full text Add to dashboard Cite

Fatigue, pain, headache, brain fog, anosmia, ageusia, mood symptoms, and sleep disorders are symptoms commonly experienced by people with post-COVID-19 condition. These symptoms could be considered as manifestations of central sensitization. The aim of this study is to evaluate whether there are indicators of central sensitization by using experimental pain measurements and to determine their association with patient-reported outcome measures (PROMs). A cross-sectional study including 42 patients after COVID-19 infection was conducted. The central sensitization inventory (CSI) was administered as a PROM to evaluate central-sensitization-associated symptoms. Pressure pain thresholds (PPT), temporal summation, and descending nociceptive pain inhibition (CPM) were assessed as experimental pain measurements. The median score on the CSI was 46.5 (Q1-Q3:33–54). The presence of central-sensitization-associated symptoms was seen in 64.3% of patients based on the CSI (≥40/100 points). A deficient CPM was seen in 12% and 14% of patients when measured at the trapezius and rectus femoris, respectively. A negative correlation between pressure sensitivity on the rectus femoris and the CSI score (r = −0.36, 95%CI −0.13 to −0.65, p = 0.007) was observed. Central-sensitization-associated symptoms were present in up to 64.3% of patients post-COVID-19 infection, based on a PROM, i.e., the CSI. A more objective evaluation of nociceptive processing through experimental pain measurements was less suggestive of indicators of central sensitization. Only a small negative correlation between pressure sensitivity and the CSI was observed, thereby pointing towards the discrepancy between the CSI and experimental pain measurements and presumably the complementary need for both to evaluate potential indicators of central sensitization in this population.

show abstract

Section: Discussionsupporting

confidence: 80%

Association between Experimental Pain Measurements and the Central Sensitization Inventory in Patients at Least 3 Months after COVID-19 Infection: A Cross-Sectional Pilot Study

Goudman

Smedt

Roggeman

et al. 2023

JCM

View full text Add to dashboard Cite

show abstract

“…The influential analysis indicated no single study had a major impact on the pooled prevalence estimate (supplementary table 3). [63] BALDINI [62] BELL [92] DARCIS [101] CARFI [96] CARVALHO-SCHNEIDER [97] CORTÉS-TELLES [59] DANKOWSKI [100] DIAZ-FUENTES [102] DREYER [103] EROL [25] GABER [106] GALVÁN-TEJADA [19] ÇALIK KÜTÜKCÜ [95] BOARI [94] MORADIAN [117] MEIJE [56] MAHMUD [114] LANDI [112] JACOBS [109] KLEIN [111] MALLIA [115] COMEBAC STUDY GROUP [85] MOTIEJUNAITE [64] GHOSN [11] GARRIGUES [53] FORTINI [36] BLOMBERG [93] ARNOLD [89] AUGUSTIN [90] ARMANAGE [88] SUÁREZ-ROBLES [128] VIJAYAKUMAR [65] VARGHESE [134] VENTURELLI [135] Subtotal (I 2 =97.8%, p<0.001) Heterogeneity between groups: p=0.014 ZHAO [138] TOSATO [133] SZEKELY [66] TAWLIK [14] TAYLOR [131] SUN [130] SHOUCRI [126] SULTANA [129] STAVEM [127] SONNWEBER ...…”

Section: Prevalence Of Post-covid Breathlessness Among Covid-19 Survi...mentioning

confidence: 99%

Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis

Zheng

Daines²,

Han³

et al. 2022

Eur Respir Rev

View full text Add to dashboard Cite

Persistent breathlessness >28 days after acute COVID-19 infection has been identified as a highly debilitating post-COVID symptom. However, the prevalence, risk factors, mechanisms and treatments for post-COVID breathlessness remain poorly understood. We systematically searched PubMed and Embase for relevant studies published from 1 January 2020 to 1 November 2021 (PROSPERO registration number: CRD42021285733) and included 119 eligible papers. Random-effects meta-analysis of 42 872 patients with COVID-19 reported in 102 papers found an overall prevalence of post-COVID breathlessness of 26% (95% CI 23–29) when measuring the presence/absence of the symptom, and 41% (95% CI 34–48) when using Medical Research Council (MRC)/modified MRC dyspnoea scale. The pooled prevalence decreased significantly from 1–6 months to 7–12 months post-infection. Post-COVID breathlessness was more common in those with severe/critical acute infection, those who were hospitalised and females, and was less likely to be reported by patients in Asia than those in Europe or North America. Multiple pathophysiological mechanisms have been proposed (including deconditioning, restrictive/obstructive airflow limitation, systemic inflammation, impaired mental health), but the body of evidence remains inconclusive. Seven cohort studies and one randomised controlled trial suggested rehabilitation exercises may reduce post-COVID breathlessness. There is an urgent need for mechanistic research and development of interventions for the prevention and treatment of post-COVID breathlessness.

show abstract

“…Another instrument for identifying patients suffering from slow or incomplete recovery is the Post-COVID-19 Functional Status (PCFS) which can also be used to track improvement over time. The PCFS is a suitable tool for assessing the impact of symptoms on the functional status of patients after a COVID-19 infection with excellent reliability and good construct validity [57][58][59].…”

Section: Discussionmentioning

confidence: 99%

Physiotherapeutic evaluation of patients with post COVID-19 condition: current use of measuring instruments by physiotherapists working in Austria and South Tyrol

et al. 2022

View full text Add to dashboard Cite

Background The implementation of standardized assessments in physiotherapeutic practice strongly supports diagnostic and treatment plans. Previous studies reported insufficient usage of standardized assessments due to lack of time, lack of knowledge, lack of resources and other barriers. Physiotherapy in outpatient settings became essential for the rehabilitation of patients with post COVID-19 condition but it remains unknown to what extent assessments are implemented into the evaluation of these patients. In this study, we explored the current use and barriers regarding the implementation of physiotherapeutic assessments to evaluate patients with post COVID-19 condition. Methods A cross-sectional online survey was carried out among 180 physiotherapists working in outpatient settings in Austria and South Tyrol. Results The majority of physiotherapists (88%) indicated that standardized assessments are useful, though less than a fifth of participants actually implement assessments in practice. Among implementation barriers, “insufficient experience” (41.8%) and “lack of knowledge” (36.6%) were mentioned most often. Concerning specific post COVID-19 assessments, the evaluation of “physical and respiratory function”, “quality of life” and “activities of daily living” were stated to be of particular relevance. Conclusions Our study revealed a low implementation rate and identified the main barriers regarding the non-usage of standardized assessments for post COVID-19 patients. Trial registration The Private University for Health Sciences and Health Technology (UMIT TIROL), and the Research Committee for Scientific Ethical Questions granted approval for the survey (RCSEQ, Hall in Tirol, Austria, Number 2834).

show abstract

Reliability and validity of the Turkish version of Post-COVID-19 Functional Status Scale

Cited by 20 publications

References 16 publications

Association between Experimental Pain Measurements and the Central Sensitization Inventory in Patients at Least 3 Months after COVID-19 Infection: A Cross-Sectional Pilot Study

Association between Experimental Pain Measurements and the Central Sensitization Inventory in Patients at Least 3 Months after COVID-19 Infection: A Cross-Sectional Pilot Study

Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis

Physiotherapeutic evaluation of patients with post COVID-19 condition: current use of measuring instruments by physiotherapists working in Austria and South Tyrol

Contact Info

Product

Resources

About